about
Pharmacological approaches to migraineNeurorescuing effects of the GAPDH ligand CGP 3466BThe neuroprotective effects of CGP 3466B in the best in vivo model of Parkinson's disease, the bilaterally MPTP-treated rhesus monkeySelective upregulation of the ubiquitin-proteasome proteolytic pathway proteins, proteasome zeta chain and isopeptidase T in fetal Down syndromeIncreased brain protein levels of carbonyl reductase and alcohol dehydrogenase in Down syndrome and Alzheimer's diseaseChanges in nicotinic acetylcholine receptor subunits expression in brain of patients with Down syndrome and Alzheimer's diseaseProtein levels of human peroxiredoxin subtypes in brains of patients with Alzheimer's disease and Down syndromeReduction of nucleoside diphosphate kinase B, Rab GDP-dissociation inhibitor beta and histidine triad nucleotide-binding protein in fetal Down syndrome brainAberrant expression of dihydropyrimidinase related proteins-2,-3 and -4 in fetal Down syndrome brainAberrant protein expression of transcription factors BACH1 and ERG, both encoded on chromosome 21, in brains of patients with Down syndrome and Alzheimer's diseaseReduction of chromatin assembly factor 1 p60 and C21orf2 protein, encoded on chromosome 21, in Down syndrome brainThe MNB/DYRK1A protein kinase: neurobiological functions and Down syndrome implicationsThe MNB/DYRK1A protein kinase: genetic and biochemical propertiesOverexpression of transcription factor BACH1 in fetal Down syndrome brainGenetic absence epilepsy in rats from Strasbourg--a reviewThe role of Pitx3 in survival of midbrain dopaminergic neuronsPINK-1 and DJ-1--new genes for autosomal recessive Parkinson's diseaseClinical and pathologic features of families with LRRK2-associated Parkinson's diseaseMolecular genetic findings in LRRK2 American, Canadian and German familiesDifferential trace amine alterations in individuals receiving acetylenic inhibitors of MAO-A (clorgyline) or MAO-B (selegiline and pargyline)Preclinical profiles of the novel reversible MAO-A inhibitors, moclobemide and brofaromine, in comparison with irreversible MAO inhibitorsThe effectiveness of interventions for children with autismOn tyramine, food, beverages and the reversible MAO inhibitor moclobemideMolecular mechanism of the relation of monoamine oxidase B and its inhibitors to Parkinson's disease: possible implications of glial cellsAre metabolites of l-deprenyl (selegiline) useful or harmful? Indications from preclinical researchPhysiological control of melatonin synthesis and secretion: mechanisms, generating rhythms in melatonin, methoxytryptophol, and arginine vasotocin levels and effects on the pineal of endogenous catecholamines, the estrous cycle, and environmental liSerotonin and 5-hydroxyindoleacetic acid in plasma. Potential use as peripheral measures of MAO-A activityToxic delirium after L-dopa medicationRo 40-7592: inhibition of COMT in rat brain and extracerebral tissuesRole of microglia in inflammation-mediated degeneration of dopaminergic neurons: neuroprotective effect of interleukin 10Chronic administration of the antidepressant phenelzine and its N-acetyl analogue: effects on GABAergic functionPossible mechanisms underlying hyperexcitability in the epileptic mutant mouse totteringDifferential trace amine alterations in individuals receiving acetylenic inhibitors of MAO-A (clorgyline) or MAO-B (selegiline and pargyline)Reduction of chromatin assembly factor 1 p60 and C21orf2 protein, encoded on chromosome 21, in Down Syndrome brainThe MNB/DYRK1A protein kinase: Neurobiological functions and Down syndrome implicationsThe MNB/DYRK1A protein kinase: Genetic and biochemical propertiesAberrant protein expression of transcription factors BACH1 and ERG, both encoded on chromosome 21, in brains of patients with Down syndrome and Alzheimer’s diseaseOverexpression of transcription factor BACH1 in fetal Down Syndrome brainFunctional imaging of Parkinson's disease: is it possible to detect brain areas for specific symptoms?Novel imaging technologies in the assessment of cerebral ageing and vascular dementia.
P1433
Q28196572-D0ECBE39-2E96-4047-8CF7-2808CE11A7D7Q28201206-AC63718B-8FCF-403F-9FB9-6E582953D88BQ28201219-012B6503-503A-4EE4-A3A6-587EAD6F8EADQ28214284-86E469A8-99B7-48E9-976D-6738EAFE9B41Q28214290-5D6F361F-5837-4CA6-A710-438D0B8928EAQ28214294-3D91E9C7-A4C8-4DEB-BABC-111FC6213837Q28214299-28CC3C64-F301-4576-A7E2-24099C7EF4EFQ28214304-274CAF69-D33A-485E-92CF-BC229B224361Q28214306-8E7A1C38-FAAA-4E14-A457-9165CCF08387Q28255003-B39F0723-C040-4A09-8023-26AB19E73EA8Q28255014-1CCDBA8B-9346-4BB0-905E-AAAE2DA61D65Q28255027-53DC9C5D-108C-4F76-B142-CD16E5DD7DE4Q28255038-53F9A943-4E70-4D25-95BE-87DFFC4A2CB4Q28255049-43BAA0B0-4BD3-47F4-8B81-B509C1160359Q28260153-422BBDCF-219D-4707-996B-F2ABB0860C12Q28266654-4428DDA1-77C5-428A-8F5D-F5A4BA9C4064Q28266665-8085DEA7-849D-4BF0-B91E-F238575FFE7CQ28266674-0E53D291-362A-4B4A-97AC-E4BD6C44807EQ28266683-CB8655FB-55D1-47CD-B5BD-9391ABD44358Q28269061-872CBEC0-4870-4465-92A7-D8E055F99285Q28272076-22D8BBC7-A52C-4C15-B43D-BF5EE6D59356Q28286956-C88CB1E5-C2BD-49ED-869F-6545CBC5FD0AQ28294755-D2B4B94C-4BFF-4A99-BD5C-B4B7C65FF366Q28298685-AB263C0A-B6D7-4025-82AF-DDE121EB6FC7Q28300866-6ECCB377-478A-44D1-A9F3-A383704F60A9Q28323804-74A34477-BCF2-42E9-AC02-A20D1808B258Q28323812-27F8BECC-00F5-49E3-8FB5-B616546C819AQ28323813-44A85C94-FFE4-4AF0-870F-4A90CCB12F75Q28328872-3FA83617-5D1C-47C1-87D8-90BC23941FB2Q28564397-0A0F32C7-2D9C-46F2-9241-66360E82554CQ28569954-FAD9A016-46EF-47DD-8462-C79FD23B1B74Q28589962-ECBAF8FD-1EFC-4EA3-8754-980A3D2502FFQ29014228-B5A57C02-F860-4D3A-B370-DE14F375198CQ29041827-56EF3128-7A38-44B9-805E-5D6765B93E96Q29299916-006454F0-2396-4BC8-8445-54AFB6EA733CQ29391627-F67C7424-5D6A-48D5-837F-ADC3C980D4DBQ29396202-C309C4D9-24CB-4F37-820C-C6AE2162D806Q29543495-9592D711-AD96-47CB-891D-68DB89747AFEQ30578269-9B1C72E4-BDDD-419E-9325-4AAEA11FCBD6Q30609636-A94D0470-D1D0-444A-B849-F76FC8665B28
P1433
description
journal
@en
revista científica
@es
rivista scientifica
@it
wetenschappelijk tijdschrift van Springer Science+Business Media
@nl
wissenschaftliche Fachzeitschrift
@de
name
Journal of neural transmission. Supplementum
@ast
Journal of neural transmission. Supplementum
@en
Journal of neural transmission. Supplementum
@es
Journal of neural transmission. Supplementum
@it
Journal of neural transmission. Supplementum
@nl
type
label
Journal of neural transmission. Supplementum
@ast
Journal of neural transmission. Supplementum
@en
Journal of neural transmission. Supplementum
@es
Journal of neural transmission. Supplementum
@it
Journal of neural transmission. Supplementum
@nl
altLabel
J Neural Transm Suppl
@en
J. Neural Transm. Suppl.
@en
prefLabel
Journal of neural transmission. Supplementum
@ast
Journal of neural transmission. Supplementum
@en
Journal of neural transmission. Supplementum
@es
Journal of neural transmission. Supplementum
@it
Journal of neural transmission. Supplementum
@nl
P1055
P1156
P1277
P1476
Journal of neural transmission. Supplementum
@en